Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Carleton

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Clinical Genetics|April 2, 2014
The emerging era of pharmacogenomics: current successes, future potential, and challengesJ W Lee, F Aminkeng, A P Bhavsar, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in childrenU Amstutz, C J D Ross, L I Castro-Pastrana, et al.
The Pharmacogenomics Journal|August 5, 2009
Application of principal component analysis to pharmacogenomic studies in CanadaH Visscher, C J D Ross, M-P Dubé, et al.
Clinical Pharmacology and Therapeutics|August 27, 2010
Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefitsP Madadi, Y Joly, D Avard, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in childrenK Pussegoda, C J Ross, H Visscher, et al.
Clinical Pharmacology and Therapeutics|March 9, 2012
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markersJ Sistonen, P Madadi, C J Ross, et al.
Clinical Pharmacology and Therapeutics|August 22, 2014
Genetic markers of cisplatin-induced hearing loss in childrenB C Carleton, C J Ross, K Pussegoda, et al.
Studies in Health Technology and Informatics|April 22, 2009
Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safetyE Wong, B C Carleton, D F B Wright, et al.
The Pharmacogenomics Journal|January 19, 2011
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatinL R Brunham, P J Lansberg, L Zhang, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 12, 2011
Sildenafil citrate therapy for severe early-onset intrauterine growth restrictionP von Dadelszen, S Dwinnell, L A Magee, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Genetics|April 2, 2014
The emerging era of pharmacogenomics: current successes, future potential, and challengesJ W Lee, F Aminkeng, A P Bhavsar, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in childrenU Amstutz, C J D Ross, L I Castro-Pastrana, et al.
The Pharmacogenomics Journal|August 5, 2009
Application of principal component analysis to pharmacogenomic studies in CanadaH Visscher, C J D Ross, M-P Dubé, et al.
Clinical Pharmacology and Therapeutics|August 27, 2010
Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefitsP Madadi, Y Joly, D Avard, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in childrenK Pussegoda, C J Ross, H Visscher, et al.
Clinical Pharmacology and Therapeutics|March 9, 2012
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markersJ Sistonen, P Madadi, C J Ross, et al.
Clinical Pharmacology and Therapeutics|August 22, 2014
Genetic markers of cisplatin-induced hearing loss in childrenB C Carleton, C J Ross, K Pussegoda, et al.
Studies in Health Technology and Informatics|April 22, 2009
Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safetyE Wong, B C Carleton, D F B Wright, et al.
The Pharmacogenomics Journal|January 19, 2011
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatinL R Brunham, P J Lansberg, L Zhang, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 12, 2011
Sildenafil citrate therapy for severe early-onset intrauterine growth restrictionP von Dadelszen, S Dwinnell, L A Magee, et al.
Pageof 3